Psychotropic Drugs: Risks and Risk Management

Abstracts (HTML) Autorenliste

Babl, M

Age- and sex-dependency of psychotropic drug induced hyperprolactinemia

Bangratz, S

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Baumann, P

Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011

Ben-Omar, N

Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV

Boland, K

Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Brandl, R

Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Brocard, M

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Brünen, S

Therapeutic drug monitoring of bupropion for depression

Crettol, S

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Deckert, J

Interaction of valproic acid and antidepressant drugs

Dörfelt, A

Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis

Dragicevic, A

Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Eap, CB

Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Egberts, K

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Eusterschulte, B

Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs

Fellgiebel, A

Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients

Frergsen, N

Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy

Fric, M

Therapeutic drug monitoring (TDM) of serotonergic antidepressants in anxiety and obsessive-compulsive disorders
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Gerlach, M

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Greil, W

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Grohmann, R

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Gründer, G

Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Haen, E

Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM
Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia
The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011

Haen, W

Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis

Hahn, M

Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward

Hansen, D

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole

Harenberg, S

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Haueis, P

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Hefner, G

Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients

Henkel, K

Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Hiemke, C

Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients
Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization
Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011
Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs
Therapeutic drug monitoring of bupropion for depression

Hilleret, H

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Himmerich, H

Agomelatine in breast milk

Huemer, J

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Jahner, T

Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Jaquenoud Sirot, E

Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)
An unusual case of abuse of nasal drops

Jonzier-Perey, M

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Karwautz, A

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Kemmerling, K

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Kirchherr, H

Agomelatine in breast milk

Köber, R

Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Köpp, A

Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM

Köppl, A

Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection

Koubek, D

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Kullak-Ublick, GA

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Kulpok, C

Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Laczkovics, C

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Laib, K

Therapeutic drug monitoring of bupropion for depression

Laux, G

Therapeutic drug monitoring (TDM) of serotonergic antidepressants in anxiety and obsessive-compulsive disorders
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Lay, C

Rabbit syndrome and akathisia in a patient treated with risperidone

Lichtblau, N

Agomelatine in breast milk

Mader, S

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Mann, K

Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Mehler-Wex, C

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Melchner, D

Measurement of the concentrations of active agents in drugs using UHPLC (Ultra High Pressure Liquid Chromatography) – and HPLC and UV-detection
Quantification of thirteen psychotherapeutic agents and their metabolites using column switching HPLC/UV

Mendonça Lima, CA

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Merl, E

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Moyses, M

Therapeutic drug monitoring of olanzapine in children and adolescents with anorexia nervosa: A pilot study

Müller, MJ

Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Onuoha, MR

The frequency and cost comparison of haloperidol prescriptions – haloperidol data analysis from therapeutic drug monitoring 2006–2011

Ostad Haji, E

Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Outlaw, EM

Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Paulzen, M

Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy
Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Perrenoud, P

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Pfeifer, P

Therapeutic drug monitoring of bupropion for depression

Pfuhlmann, B

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice
Interaction of valproic acid and antidepressant drugs

Plener, P

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Powell Golay, K

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Rao, ML

Cost-effectiveness potential of therapeutic drug monitoring for depressed inpatients treated with citalopram by shortening of hospitalization

Reich, A

Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Riederer, P

Interaction of valproic acid and antidepressant drugs

Roll, SC

Increasing drug therapy safety in psychiatry: implementing a pharmacist on the ward

Russmann, S

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Schäfer, A

Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011

Schmidt, FM

Agomelatine in breast milk

Schultze, I

Therapeutic drug monitoring (TDM) and clinical outcomes in forensic patients under clozapine therapy compared to therapies with other antipsychotic drugs

Spisla, C

An unusual case of abuse of nasal drops
Rabbit syndrome and akathisia in a patient treated with risperidone

Stegmann, B

Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis

Stephan, PL

Matched case-control study: therapeutic drug monitoring in pharmacovigilance
Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)

Suter, K

Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)

Tauber, S

Plasma levels and cerebrospinal fluid penetration of venlafaxine in a patient with a non-fatal overdose during a suicide attempt

Taurines, R

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Unterecker, S

Interaction of valproic acid and antidepressant drugs

Uribe, MM

Agomelatine in breast milk

Vandel, P

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

van der Velden, JW

Matched case-control study: therapeutic drug monitoring in pharmacovigilance

Veselinovic, T

Therapeutic drug monitoring (TDM) in plasma and amniotic fluid in pregnancy

Vincent, P

Therapeutic drug monitoring of bupropion for depression

Waldner-Knogler, K

Lack of response or side effects despite therapeutic dosing: drug-drug interactions? An indication for Therapeutic Drug Monitoring (TDM)

Wenzel-Seifert, K

Age-dependency of the risk for tricyclic antidepressant-associated anticholinergic adverse reactions
Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine
Depressive disorders in childhood and adolescence 2010– a KinderAGATE analysis
Age- and sex-dependency of psychotropic drug induced hyperprolactinemia

Wewetzer, C

Therapeutic drug monitoring (TDM) in children and adolescents treated with aripiprazole
Relation between dosage, serum concentration and therapeutic response of quetiapine in children and adolescents with different psychiatric disorders in clinical practice

Wittmann, K

Enzyme assay to study the metabolism of quetiapine and the influence of psychotropic comedication on the concentration of quetiapine

Wolf, M

Beta-blockers in psychiatry: Pharmacokinetic interactions of antipsychotics with CYP2D6- HPLC as a quantitative method for analysis in TDM

Zorina, OL

Comparative performance of two drug interaction screening programs analyzing a cross-sectional prescription dataset of 84,625 psychiatric inpatients

Zullino, DF

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression